MediWound Ltd. (MDWD) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, everyone, and welcome to MediWUN's fourth quarter and full year 2025 earnings call. Today's conference call is being recorded. At this time, I would like to turn the conference call over to Gaia Shamus of LifeSci Advisors. Please go ahead. Thank you, operator, and welcome, everyone. Earlier today, pre-market open, MediWound issued a press release announcing financial results for the fourth quarter and full year ended December 31st, 2025. You may access this press release on the company's website under the Investors tab. I would ask you to review the full text of our forward-looking statement within this morning's press release. Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to MediWon's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from expectations and are described more fully in our filings with the SEC. In addition, all forward-looking statements represent our views only as of today, and MediWound assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events, or otherwise. This conference call is a property of Mediwound, and any recording or rebroadcast is expressly prohibited without the written consent of Mediwound. With us today are Ofer Gunen, Chief Executive Officer of Mediwound, and Hani Luxemburg, Chief Financial Officer. Barry Wolfenson, EVP of Strategy and Corporate Development, is also participating in today's call. Following our prepared remarks, we will open ...